Erschienen in:
13.11.2019 | Commentary
Could the impact of photobiomodulation on tumor response to radiation be effected by tumor heterogeneity?
verfasst von:
Stephen Sonis
Erschienen in:
Supportive Care in Cancer
|
Ausgabe 2/2020
Einloggen, um Zugang zu erhalten
Excerpt
Low-level laser therapy or photobiomodulation (PBM) has been enthusiastically embraced for its potential to treat or prevent a broad range of conditions—from snake bite (
1) to cognitive dysfunction (
2). Of all its potential applications, mitigation of cancer therapy-related toxicities, including oral mucositis, is potentially one of the most promising. While data supporting some PBM indications is soft, there is a substantial amount of literature to suggest that PBM may be an effective intervention for oral mucositis associated with cancer chemotherapy and radiation regimens (
3). …